Ten years after BRCA1 and BRCA2 were first identified as major breast cancer susceptibility genes, the spectrum of mutat...
...BRCA2 mutations and to determine to what extent risk reduction varies with age at oophorectomy, age at diagnosis, and ti...
...BRCA2 and non-BRCA1/2 tumors, but have not identified differences between BRCA2 and non-BRCA1/2 tumors. Because BRCA1 an...
...BRCA2 (BRCA1/2) as well as genes TP53 and PTEN. Since 1996, genetic testing for these mutations has been clinically avai...
...BRCA2). Issues addressed touch on the evolution of the subfield, its potential impact on cancer treatment, and industry ...
...BRCA2.
...BRCA2) to identify melanoma susceptibility genes. Results of parametric linkage analysis are presented as logarithm of t...
...BRCA2 mutation are at increased risk for ovarian cancer. It is less clear, however, whether individuals from hereditary ...
Identifying BRCA1 and BRCA2 mutation carriers is increasingly important as new management options show promise in decrea...
The EMSY gene encodes a protein that interacts with Brca2 and is amplified in some sporadic cases of human breast cancer...
Contact
No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong
Qilu Normal University · Genelibs Bioinformatics Lab
750 Shunhua Rd, Jinan
2F, Bldg F, University Science Park
Tel: 0531-88819269
WeChat Official Account
Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.
Business Email
E-mail: product@genelibs.com
Copyright © 2026.Genelibs Jinan Honghui Biotechnology Co., Ltd. 鲁ICP备20007159号-2
